Comments
Loading...

Inhibitor Therapeutics

INTIOTCQB
Logo brought to you by Benzinga Data
$0.0659
At close: Feb 14, 3:50 PM EDT

Inhibitor Therapeutics (OTC:INTI) Stock Quotes, Forecast and News Summary

Inhibitor Therapeutics Stock (OTC: INTI) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 48.77K
Day Range- - -
52 Wk Range0.04 - 0.14
Market Cap$11.36M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1

Recent News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open-
Close-
Volume / Avg.0 / 48.77K
Day Range- - -
52 Wk Range0.04 - 0.14
Market Cap$11.36M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1
About Inhibitor Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Inhibitor Therapeutics Inc is a pharmaceutical development company that is focused on developing and...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INTI

FAQ

Q

How do I buy Inhibitor Therapeutics (INTI) stock?

A

You can purchase shares of Inhibitor Therapeutics (OTCQB:INTI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inhibitor Therapeutics (INTI) competitors?

A

There are no as such competitors for Inhibitor Therapeutics.

Q

What is the forecast, or price target, for Inhibitor Therapeutics (INTI) stock?

A

There is no analysis for Inhibitor Therapeutics to provide a consensus price target.

Q

What is the current price for Inhibitor Therapeutics (INTI)?

A

The stock price for Inhibitor Therapeutics (OTCQB: INTI) is $0.08 last updated August 20, 2024 at 4:22 PM EDT.

Q

Does Inhibitor Therapeutics (INTI) pay a dividend?

A

There are no upcoming dividends for Inhibitor Therapeutics.

Q

When is Inhibitor Therapeutics (OTCQB:INTI) reporting earnings?

A

Inhibitor Therapeutics does not have any upcoming earnings scheduled.

Q

Is Inhibitor Therapeutics (INTI) going to split?

A

There is no upcoming split for Inhibitor Therapeutics.

Q

What sector and industry does Inhibitor Therapeutics (INTI) operate in?

A

Inhibitor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.